Background/aimsThe clinical syndromes of frontotemporal lobar degeneration include behavioral variant frontotemporal dementia (bvFTD) and semantic (SV-PPA) and nonfluent variants (NF-PPA) of primary progressive aphasia. Using magnetic resonance imaging (MRI), tensor-based morphometry (TBM) was used to determine distinct patterns of atrophy between these three clinical groups.MethodsTwenty-seven participants diagnosed with bvFTD, 16 with SV-PPA, and 19 with NF-PPA received baseline and follow-up MRI scans approximately 1 year apart. TBM was used to create three-dimensional Jacobian maps of local brain atrophy rates for individual subjects.ResultsRegional analyses were performed on the three-dimensional maps and direct comparisons between gro...
Frontotemporal lobe dementia is a degenerative brain condition characterised by focal atrophy affect...
BACKGROUND: Two major clinical variants of frontotemporal dementia (FTD) have been described: fronta...
OBJECTIVES: There is currently much interest in biomarkers of disease activity in frontotemporal lob...
Objective: Predictable patterns of atrophy are associated with the clinical subtypes of frontotempor...
Objective: Predictable patterns of atrophy are associated with the clinical subtypes of frontotem-po...
White matter (WM) tract damage was assessed in patients with the behavioral variant frontotemporal d...
<p>Voxel-based morphometry analyses showing brain regions of decreased grey matter intensity in beha...
BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration (FTLD) is a primary neurodegenerative dise...
Though neuroimaging, pathology and pathophysiology suggest a subcortical and deep cortical involveme...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
BACKGROUND: Two major clinical variants of frontotemporal dementia (FTD) have been described: fronta...
Frontotemporal lobe dementia is a degenerative brain condition characterised by focal atrophy affect...
BACKGROUND: Two major clinical variants of frontotemporal dementia (FTD) have been described: fronta...
OBJECTIVES: There is currently much interest in biomarkers of disease activity in frontotemporal lob...
Objective: Predictable patterns of atrophy are associated with the clinical subtypes of frontotempor...
Objective: Predictable patterns of atrophy are associated with the clinical subtypes of frontotem-po...
White matter (WM) tract damage was assessed in patients with the behavioral variant frontotemporal d...
<p>Voxel-based morphometry analyses showing brain regions of decreased grey matter intensity in beha...
BACKGROUND AND PURPOSE: Frontotemporal lobar degeneration (FTLD) is a primary neurodegenerative dise...
Though neuroimaging, pathology and pathophysiology suggest a subcortical and deep cortical involveme...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
International audienceGray matter (GM) lobar atrophy and glucose hypometabolism are well-described h...
BACKGROUND: Two major clinical variants of frontotemporal dementia (FTD) have been described: fronta...
Frontotemporal lobe dementia is a degenerative brain condition characterised by focal atrophy affect...
BACKGROUND: Two major clinical variants of frontotemporal dementia (FTD) have been described: fronta...
OBJECTIVES: There is currently much interest in biomarkers of disease activity in frontotemporal lob...